Anakinra for the Treatment of Severe Still's Disease Complicated With Macrophage Activation Syndrome
Medicine
Abstract
To investigate the efficacy and safety of add‐on anakinra for severe Still's disease complicated by macrophage activation syndrome (MAS) in a real‐world setting.